The Korean government presented a draft of its plan during a meeting for the foreign drug price comparison reevaluations that was held on the 26th. The government’s foreign drug price comparison reevaluation was planned by the government to adjust the price of off-patent drugs by comparing their price to the upper limit of A8 countries (Japan, France, Germany, Italy, Switzerland, the United Kingdom, and Canada). The plan was included in the government's 2nd Comprehensive National Health Insurance Plan as a measure to strengthen the fiscal soundness of Korea’s health insurance finances.

At the 8th meeting that was held on the morning of the 26th at the Kukje Electronics Center in Seocho-gu, Seoul, th